Loading clinical trials...
Loading clinical trials...
The Comprehensive Program for Hereditary Transthyretin Amyloidosis describes a prospective observational study focused on understanding hereditary transthyretin amyloidosis (ATTR), a progressive and p...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospital de Alta Complejidad en Red
NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more
NCT05489549 · Amyloidosis, Hereditary, Amyloidosis Cardiac, and more
NCT01623245 · Cardiac Amyloidosis, Amyloidosis in Transthyretin (TTR), and more
Hospital Cuenca Alta de Cañuelas
Canuelas, Buenos Aires
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions